alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 4,451–4,475 of 7,816 matching trials · page 179 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Improvisational Movement for People With Memory Loss and Their Caregivers
NCT03333837
Dance Group; Non-Group Dance; Social Group; No Contact
Runs in: United States · 1 site 		NA
other		 COMPLETED 104 Wake Forest University Health Sciences
OTHER		 2022-07-27
The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease
NCT04096261
Diagnostic Test
Runs in: Germany · 1 site 		NA
other		 WITHDRAWN 0 Charite University, Berlin, Germany
OTHER		 2022-07-27
NightCAP: Reducing Hypnotic Drug Use and Improving Night-time Care
NCT04373668
Hypnotic Medication Review; Structured Sleep Hygiene; Night Time Ca...
Runs in: United Kingdom · 1 site 		NA
other		 UNKNOWN 720 University of Exeter
OTHER		 2022-07-27
Effect of Music Therapy on Anxiety of Caregivers of Alzheimer's Disease Patients
NCT05317910
MUSIC CARE
Runs in: France · 1 site 		NA
other		 COMPLETED 26 Association de Musicothérapie Applications et Recherches Cliniques
OTHER		 2022-07-27
Effect of Remote Cognitive Intervention in Patients With Parkinson's Disease During the COVID-19 Pandemic
NCT05476302
Cognitive digital treatment
Runs in: Italy · 1 site 		NA
other		 COMPLETED 18 Istituto Nazionale di Ricovero e Cura per Anziani
OTHER		 2022-07-27
Version 2 of the Smoking Cessation Smartphone App "Smiling Instead of Smoking" (SiS)
NCT03951766
Smiling Instead of Smoking (SiS) App Version 2
Runs in: United States · 1 site 		NA
other		 COMPLETED 100 Massachusetts General Hospital
OTHER		 2022-07-26
Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults With Dementia
NCT04338750
Telephone Acceptance and Commitment Therapy Intervention for Caregi...
Runs in: United States · 1 site 		NA
other		 COMPLETED 60 Indiana University
OTHER		 2022-07-26
Comparison of the Effect of Online Physical Exercise and Computerized Cognitive Stimulation in Patients With Alzheimer's Disease
NCT04842734
Physical exercise; Physical exercise and computerized cognitive training
Runs in: Turkey (Türkiye) · 1 site 		NA
other		 COMPLETED 60 Yeditepe University
OTHER		 2022-07-26
Self-help App and Wellbeing
NCT04911803
Anxiety Application; Procrastination Application
Runs in: Singapore · 1 site 		NA
other		 COMPLETED 492 VTan
OTHER		 2022-07-26
Comparison of OCTA Factors in Patients With or Without Amyloid Pathology: A Prospective Study
NCT05475158
Runs in: South Korea · 1 site 		NA
other		 COMPLETED 117 Pusan National University Hospital
OTHER		 2022-07-26
Music and Essential Oil in Agitation
NCT04722614
Music; Essential oil; Control
Runs in: Egypt · 2 sites 		NA
other		 COMPLETED 123 Alexandria University
OTHER		 2022-07-25
Effects of Cognicise and Arch Support Insoles in Older Adults With Mild Cognitive Impairment
NCT05472415
cognicise; arch support insoles
Runs in: Taiwan · 1 site 		NA
other		 UNKNOWN 40 National Taipei University of Nursing and Health Sciences
OTHER		 2022-07-25
Comparison of Physical Fitness, Walking Speed, Reaction Time In Older Adults With and Without Mild Cognitive Impairment
NCT05472727
reaction time test; Physical fitness test 		NA
other		 UNKNOWN 60 Dokuz Eylul University
OTHER		 2022-07-25
BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)
NCT02502253
grape seed polyphenolic extract, resveratrol
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 14 Johns Hopkins University
OTHER		 2022-07-22
Local Study of Akatinol Memantine in VaD in Russia
NCT03986424
Akatinol Memantine 20 mg; Akatinol Memantine 10 mg
Runs in: Russia · 4 sites 		PHASE3
symptomatic-cholinergic		 COMPLETED 130 Merz Pharmaceuticals GmbH
INDUSTRY		 2022-07-22
Evaluating the Community Areas of Sustainable Care and Dementia Excellence Model of Care
NCT04258358
CASCADE ways of working
Runs in: United Kingdom · 2 sites 		NA
other		 WITHDRAWN 0 Canterbury Christ Church University
OTHER		 2022-07-22
Arch Support Effects on Balance and Gait in Older Adults With Mild Cognitive Impairment
NCT05470062
arch support insoles (FootDisc)
Runs in: Taiwan · 1 site 		NA
other		 UNKNOWN 40 National Taipei University of Nursing and Health Sciences
OTHER		 2022-07-22
Noninvasive Brain Stimulation for pAD
NCT05468268
20 Hz rTMS; Sham rTMS
Runs in: Italy · 1 site 		NA
other		 UNKNOWN 40 Università degli Studi di Trento
OTHER		 2022-07-21
China Longitudinal Aging and Cognitive Impairment Study
NCT05468905
None of intervention
Runs in: China · 2 sites 		NA
other		 RECRUITING 4,000 Second Affiliated Hospital, Zhejiang University, School of Medicine
OTHER		 2022-07-21
Deep Brain Stimulation Treatment for Chorea in Huntington's Disease
NCT04244513
Deep brain stimulation
Runs in: China · 3 sites 		NA
other		 UNKNOWN 40 Beijing Municipal Administration of Hospitals
OTHER_GOV		 2022-07-20
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ACD856
NCT05077501
ACD856; Placebo
Runs in: Sweden · 1 site 		PHASE1
other		 COMPLETED 24 AlzeCure Pharma
INDUSTRY		 2022-07-20
Study to Evaluate the Effects of Single Ascending Oral Doses of ACD856 on Safety, Tolerability and Pharmacokinetics
NCT05077631
ACD856; Placebo; ACD856 (fed cohort)
Runs in: Sweden · 1 site 		PHASE1
other		 COMPLETED 56 AlzeCure Pharma
INDUSTRY		 2022-07-20
Lifestyle Integrated Functional Exercise for People With Dementia: a Home-based Physical Activity Program
NCT03757806
Experimental group
Runs in: Portugal · 1 site 		NA
other		 COMPLETED 56 Aveiro University
OTHER		 2022-07-19
The Prevention Program for Alzheimer's Related Delirium (PREPARED) Trial
NCT03718156
PREPARED Trial Intervention
Runs in: Canada · 6 sites 		NA
other		 SUSPENDED 800 McGill University
OTHER		 2022-07-15
ANAVEX2-73 for Treatment of Early Alzheimer's Disease
NCT03790709
High dose ANAVEX2-73; Mid dose ANAVEX2-73; Placebo oral capsule
Runs in: Australia; Canada; Germany; Netherlands; United Kingdom · 54 sites 		PHASE2|PHASE3
other		 COMPLETED 509 Anavex Life Sciences Corp.
INDUSTRY		 2022-07-14

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →